Literature DB >> 23111455

Quantitative assessment of the influence of PSMA6 variant (rs1048990) on coronary artery disease risk.

Hairong Wang1, Mei Jiang, Hua Zhu, Qihong Chen, Peihua Gong, Jie Lin, Jide Lu, Jianping Qiu.   

Abstract

The proteasome system is a proteolytic pathway that regulates the expression of genes involved in inflammation. Recently, an association of a functional sequence variation, -8C/G, in the human proteasome subunit a type 6 gene (PSMA6) with the susceptibility to coronary artery disease (CAD) was reported. After that, several validation studies have been conducted among various ethnic populations, but the results have been inconsistent. To investigate this inconsistency and derive a more precise estimation of the relationship, a meta-analysis of 15,991 cases and 16,784 controls from 10 case-control studies was performed. Potential sources of heterogeneity including ethnicity, sample size and HWE status of study were also assessed. In a combined analysis, the summary per-allele OR for CAD of the -8C/G polymorphism was 1.09 (95 % CI: 1.02-1.16; P = 0.006). In the subgroup analysis by ethnicity, significantly increased risks were found in East Asians for the polymorphism; while no significant associations were found among Caucasians and other ethnic population in all genetic models. When restricted to studies concerning myocardial infarction patients, significant associations were detected in all genetic models. Furthermore, significant difference of PSMA6 mRNA expression was found between genotypes. In conclusion, this meta-analysis suggests that G allele of PSMA6-8C/G polymorphism is a risk factor associated with increased CAD susceptibility, but these associations vary in different ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111455     DOI: 10.1007/s11033-012-2146-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

Review 1.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

3.  The exon 1-8C/G SNP in the PSMA6 gene contributes only a small amount to the burden of myocardial infarction in 6946 cases and 2720 controls from a United Kingdom population.

Authors:  Derrick A Bennett; Peng Xu; Robert Clarke; Krina Zondervan; Sarah Parish; Alison Palmer; Lon Cardon; Richard Peto; Mark Lathrop; Rory Collins
Journal:  Eur J Hum Genet       Date:  2008-01-30       Impact factor: 4.246

Review 4.  Structure and functions of the 20S and 26S proteasomes.

Authors:  O Coux; K Tanaka; A L Goldberg
Journal:  Annu Rev Biochem       Date:  1996       Impact factor: 23.643

5.  Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6.

Authors:  M Kozak
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

Review 6.  Proteasome inhibition: a new anti-inflammatory strategy.

Authors:  Peter J Elliott; Thomas Matthias Zollner; Wolf-Henning Boehncke
Journal:  J Mol Med (Berl)       Date:  2003-03-26       Impact factor: 4.599

7.  Validation of the association between the gene encoding proteasome subunit alpha type 6 and myocardial infarction in a Japanese population.

Authors:  Naoyuki Takashima; Keisuke Shioji; Yoshihiro Kokubo; Akira Okayama; Yoichi Goto; Hiroshi Nonogi; Naoharu Iwai
Journal:  Circ J       Date:  2007-04       Impact factor: 2.993

8.  The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population.

Authors:  Xin Liu; Xingyu Wang; Yue Shen; Lijun Wu; Xiaoyang Ruan; Klaus Lindpaintner; Salim Yusuf; James C Engert; Sonia Anand; Xuerui Tan; Lisheng Liu
Journal:  Atherosclerosis       Date:  2009-02-12       Impact factor: 5.162

9.  SNPs of PSMA6 gene--investigation of possible association with myocardial infarction and type 2 diabetes mellitus.

Authors:  T Sjakste; I Poudziunas; E Ninio; C Perret; V Pirags; V Nicaud; M Lazdins; A Evanss; C Morrison; F Cambien; N Sjakste
Journal:  Genetika       Date:  2007-04

Review 10.  Pushing the limits of the scanning mechanism for initiation of translation.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2002-10-16       Impact factor: 3.688

View more
  7 in total

1.  Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals.

Authors:  Tatjana Sjakste; Natalia Paramonova; Kristine Osina; Kristine Dokane; Jelizaveta Sokolovska; Nikolajs Sjakste
Journal:  Mol Genet Genomics       Date:  2015-12-12       Impact factor: 3.291

2.  Polymorphism of Proteasomal Genes Can Be a Risk Factor for Systemic Autoimmune Diseases in Children.

Authors:  Ivan Y Bakutenko; Irena D Hileuskaya; Natalia V Nikitchenko; Elena V Sechko; Alexej M Tchitchko; Galina M Batyan; Alexander V Sukalo; Nadezhda I Ryabokon
Journal:  J Pediatr Genet       Date:  2020-08-04

3.  Association of obesity with proteasomal gene polymorphisms in children.

Authors:  Sarmite Kupca; Tatjana Sjakste; Natalija Paramonova; Olga Sugoka; Irena Rinkuza; Ilva Trapina; Ilva Daugule; Alfred J Sipols; Ingrida Rumba-Rozenfelde
Journal:  J Obes       Date:  2013-12-21

4.  PSMA6 (rs2277460, rs1048990), PSMC6 (rs2295826, rs2295827) and PSMA3 (rs2348071) genetic diversity in Latvians, Lithuanians and Taiwanese.

Authors:  Tatjana Sjakste; Natalia Paramonova; Lawrence Shi-Shin Wu; Zivile Zemeckiene; Brigita Sitkauskiene; Raimundas Sakalauskas; Jiu-Yao Wang; Nikolajs Sjakste
Journal:  Meta Gene       Date:  2014-04-17

5.  Genetics of proteasome diseases.

Authors:  Aldrin V Gomes
Journal:  Scientifica (Cairo)       Date:  2013-12-30

6.  Association between functional variant of inflammatory system gene (PSMA6) and end-stage kidney disease.

Authors:  Monika Buraczynska; Anna Stec; Aleksandra Filipczak; Andrzej Ksiazek
Journal:  Int Urol Nephrol       Date:  2016-09-26       Impact factor: 2.370

7.  Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.

Authors:  Yunan He; Sen Zeng; Shunjie Hu; Fengqian Zhang; Nianchun Shan
Journal:  Front Genet       Date:  2020-10-15       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.